Based on results of previous studies, [23-25], however, we postulated that senescent stroma can contribute to disease progression by secreting inflammatory mediators, cytokines, and enzymes such as proteases, providing a mechanism through which p16-positive stroma contributes to tumor progression and/or invasion. Here, CDKN2A is linked to neoplasm.